Stereotactic Ablative Radiation Therapy (SABR) for Adolescent and Young Adult Malignancies

SABR with BED₁₀ ≥ 60 Gy resulted in durable LC for AYA patients, particularly those with sarcoma primaries, though poor outcomes were noted in metastatic CNS malignancies.